The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000913370
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
18/06/2026
Date registered
Help: Date registered
24/07/2026
Date last updated
Help: Date last updated
24/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
24/07/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
Perilymph Analysis in Cochlear Implant Recipients
Scientific title
Perilymph Analysis in Cochlear Implant Recipients
Additional trial identifiers [1] 317590 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Sensorineural hearing loss 342351 0
Condition category
Condition code
Ear 338483 338483 0 0
Deafness

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of the intervention or exposure
The study recruits participants who are eligible to receive a cochlear implant, typically with severe or profound sensorineural hearing loss in at least one ear.

During cochlear implant surgery, a small amount (2-5 micro-liters) of perilymph (fluid within the cochlea) will be sampled for the purposes of micro-RNA (miRNA) analysis. Participants will be given the option to have their sample undergo whole exome sequencing.

Participants will also undergo Electrocochleography during surgery and at surgical follow-up 1 day, 1 month and 3 months post-op. Electrocochleography (ECochG) is an objective test that measures the electrical potentials generated by the inner ear (cochlea) in response to sound. This testing is done to observe the function of the cochlear sensory cells during insertion of the cochlear implant electrode and during recovery after surgery. Participants will also have hearing tests (pure-tone audiometry and speech testing) at follow up visits.

Intervention code [1] 334441 0
Not applicable
Description of the comparator or control
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 345803 0
microRNA transcriptome analysis derived from perilymph sampling.
Timepoint [1] 345803 0
Surgery
Primary outcome [2] 345953 0
Cochlear implant function measured by objective electrophysiological assessment
Timepoint [2] 345953 0
Surgery and follow up visits at 1 day, 1 month and 3 months post-op.
Secondary outcome [1] 463377 0
Pure-tone hearing thresholds and speech perception assessed as a composite outcome.
Timepoint [1] 463377 0
Follow up visits at 1 day, 1 month and 3 months post-op.

Eligibility
Key inclusion criteria
All adult and paediatric cochlear implant recipients
Minimum age
No limit
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
- Unwilling to comply with study requirements ie. attendance at post-op reviews.

Study design
Purpose
Duration
Selection
Timing
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 322145 0
Charities/Societies/Foundations
Name [1] 322145 0
Passe & Williams Foundation
Country [1] 322145 0
Australia
Primary sponsor type
University
Name
University of Melbourne
Address
Country
Australia
Secondary sponsor category [1] 325072 0
None
Name [1] 325072 0
Address [1] 325072 0
Country [1] 325072 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320676 0
The Royal Children’s Hospital Human Research Ethics Committee
Ethics committee address [1] 320676 0
Ethics committee country [1] 320676 0
Australia
Date submitted for ethics approval [1] 320676 0
07/03/2023
Approval date [1] 320676 0
10/03/2023
Ethics approval number [1] 320676 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151250 0
Prof Stephen O'Leary
Address 151250 0
Royal Victorian Eye and Ear Hospital, Level 5, 32 Gisborne Street, East Melbourne VIC 3002
Country 151250 0
Australia
Phone 151250 0
+61 3 9929 8366
Fax 151250 0
Email 151250 0
Contact person for public queries
Name 151251 0
Stephen O'Leary
Address 151251 0
Royal Victorian Eye and Ear Hospital, Level 5, 32 Gisborne Street, East Melbourne VIC 3002
Country 151251 0
Australia
Phone 151251 0
+61 3 9929 8366
Fax 151251 0
Email 151251 0
Contact person for scientific queries
Name 151252 0
Stephen O'Leary
Address 151252 0
Royal Victorian Eye and Ear Hospital, Level 5, 32 Gisborne Street, East Melbourne VIC 3002
Country 151252 0
Australia
Phone 151252 0
+61 3 9929 8366
Fax 151252 0
Email 151252 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.